Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
The Aplar Recommendations for the Management of Psoriatic Arthritis Publisher Pubmed



Yy Leung Ying YING ; Pa Bird Paul A ; M Haroon MUHAMMAD ; M Kishimoto MITSUMASA ; K Shin KICHUL ; Aj Mathew Ashish JACOB ; Hbm Reyes Heizel BM ; J Chau JEFFREY ; Dr Neuen Dennis RYAN ; P Chiowchanwisawakit PRAVEENA
Authors

Source: International Journal of Rheumatic Diseases Published:2025


Abstract

Objectives: Under the auspices of the Asia-Pacific League of Associations for Rheumatology (APLAR), we aimed to develop broad, evidence- and consensus-based guidelines to aid health professionals managing patients with psoriatic arthritis (PsA) in the region. Methods: A working group of 35 members comprising rheumatologists, dermatologists, and patient research partners from 18 APLAR countries was convened. The working group conducted systematic literature reviews to derive the quality of evidence via GRADE methods in supporting the efficacy and safety of classes of therapeutic agents for the management of active PsA, its comorbidities, and screening for specific infection concerns in the region. Recommendation statements on the principles of management and the best use of therapeutic drugs were developed. Consensus within the working group was achieved. An external voting panel, five from each of the 18 APLAR countries, was convened to confirm further agreement on the recommendation statements. Results: The main literature review included 178 articles from clinical trials for PsA. Additional articles on the evidence for managing comorbidities, uveitis, inflammatory bowel disease, and screening for chronic hepatitis B and latent tuberculosis were reviewed. The working group discussed and reached consensus on eight management principles and 16 recommendation statements for managing PsA. Endorsement from an external voting panel (n = 90, response rate 80%) was achieved. Conclusion: These first recommendations for the management of PsA patients in the APLAR regions were developed based on the best available evidence and region-specific considerations through discussion among rheumatologists, dermatologists, and patients, with strong agreement from an external expert panel. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. A Phase Iii, Randomized, Two-Armed, Double-Blind, Parallel, Active Controlled, and Non-Inferiority Clinical Trial to Compare Efficacy and Safety of Biosimilar Adalimumab (Cinnora®) to the Reference Product (Humira®) in Patients With Active Rheumatoid Arthritis, Arthritis Research and Therapy (2017)
2. A Systematic Review and Meta-Analysis of Investigating the Mutual Impact of Covid-19 and Psoriasis: Focusing on Covid-19 Course in Psoriasis and the Opinion on Biologics in This Setting, Immunity# Inflammation and Disease (2023)
3. An Update on Clinically Evaluated Medicinal Plants for Psoriasis Management, Current Drug Discovery Technologies (2025)
Experts (# of related papers)
View all Related Experts
Maryam Daneshpajooh (3)
Kamran Balighi (3)
Other Related Docs
4. The Effect of Melissa Officinalis Syrup on Patients With Mild to Moderate Psoriasis: A Randomized, Double-Blind Placebo-Controlled Clinical Trial, BMC Research Notes (2021)
5. Trend of C-Reactive Protein and Erythrocyte Sedimentation Rates in Psoriatic Patients on Treatment of Standard Protocol of Infliximab, Galen Medical Journal (2015)
6. A Comprehensive Review of Rituximab Therapy in Rheumatoid Arthritis Patients, Clinical Rheumatology (2019)
7. 2018 Aplar Axial Spondyloarthritis Treatment Recommendations, International Journal of Rheumatic Diseases (2019)
8. The Efficacy of Methotrexate Plus Pioglitazone Vs: Methotrexate Alone in the Management of Patients With Plaque-Type Psoriasis: A Single-Blinded Randomized Controlled Trial, International Journal of Dermatology (2015)
9. Evaluating the Persian Versions of Two Psoriatic Arthritis Screening Questionnaires Early Arthritis for Psoriatic Patients Questionnaire (Earp) and Psoriasis Epidemiology Screening Tool (Pest) in Iranian Psoriatic Patients, Turkish Journal of Medical Sciences (2021)
10. Evaluation of Chronic Kidney Disease and Associated Factors in Psoriasis Patients at Razi Hospital, Tehran, Iran, Tehran University Medical Journal (2022)
11. Exploring the Association Between Blood Indices and Skin and Joint Activity of Psoriatic Arthritis, Iranian Journal of Allergy, Asthma and Immunology (2024)
12. Infections in Hospitalized Patients With Psoriasis in a Skin Referral Hospital, Dermatology Practical and Conceptual (2023)
13. Treatment Resistance to Tnf- Α Inhibitors in Patients With Psoriasis, Dermatologic Therapy (2023)
14. Validating the “Treatment Satisfaction Questionnaire for Medication” in Persian, and Evaluating Treatment Satisfaction Among Patients With Psoriasis, Value in Health Regional Issues (2022)
15. Efficacy of Hydrotherapy, Spa Therapy, and Balneotherapy for Psoriasis and Atopic Dermatitis: A Systematic Review, International Journal of Dermatology (2023)
16. Assessment of the Therapeutic Aspect of Systemic Non-Biologic Anti-Psoriatic Treatment Modalities Used in Combination With Methotrexate, Indian Journal of Dermatology (2016)
17. Immunosuppressive Drugs for Patients With Psoriasis During the Covid-19 Pandemic Era. a Review, Dermatologic Therapy (2021)
18. Metabolic Syndrome and Its Components Among Rheumatoid Arthritis Patients: A Comprehensive Updated Systematic Review and Meta-Analysis, PLoS ONE (2017)
19. Estimation of Diagnostic Markers in Rheumatoid Arthritis and Ankylosing Spondylitis, Clinical Laboratory (2017)
20. In the Absence of Specific Advice, What Do Patients Eat and Avoid? Results From a Community Based Diet Study in Patients Suffering From Rheumatoid Arthritis (Ra) With a Focus on Potassium, Clinical Nutrition ESPEN (2018)